ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients

J M van Dieren, A J van Vuuren, J G Kusters, E E S Nieuwenhuis, E J Kuipers, C J van der Woude

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1664
JournalGut
Volume54
Issue number11
Publication statusPublished - Nov 2005

Keywords

  • Azathioprine
  • Humans
  • Immunosuppressive Agents
  • Inflammatory Bowel Diseases
  • Methyltransferases
  • Polymorphism, Genetic
  • Pyrophosphatases

Cite this